Aminov Erez 4
4 · MIRA PHARMACEUTICALS, INC. · Filed Sep 18, 2025
Insider Transaction Report
Form 4
Aminov Erez
DirectorCEO and Chairman
Transactions
- Award
Stock Options (right to buy)
2025-09-18+150,000→ 150,000 totalExercise: $1.38Exp: 2033-04-28→ Common Stock (150,000 underlying) - Award
Stock Options (right to buy)
2025-09-18+150,000→ 150,000 totalExercise: $1.38Exp: 2033-08-17→ Common Stock (150,000 underlying)
Footnotes (5)
- [F1]The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on September 15, 2025.
- [F2]The board of directors of the Company approved to reprice the options from its previous exercise price of $5.00 to $1.38. All of the other terms of the option remain unchanged.
- [F3]The options were previously issued to the Reporting Person on April 28, 2023, and are now fully vested.
- [F4]The board of directors of the Company approved to reprice the options from its previous exercise price of $6.50 to $1.38. All of the other terms of the option remain unchanged.
- [F5]The options were previously issued to the Reporting Person on August 17, 2023, and are now fully vested.